Results of conservative management of epithelial malignant and borderline ovarian tumours

被引:73
作者
Morice, P
Camatte, S
Wicart-Poque, F
Atallah, D
Rouzier, R
Pautier, P
Pomel, C
Lhommé, C
Duvillard, P
Castaigne, D
机构
[1] Inst Gustave Roussy, Dept Gynecol Surg, Serv Chirurg Gynecol, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Dept Gynecol, F-94805 Villejuif, France
[3] Inst Gustave Roussy, Dept Pathol, F-94805 Villejuif, France
关键词
borderline tumour; conservative surgery; infertility treatment; ovarian cancer; pregnancy;
D O I
10.1093/humupd/dmg006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Conservative management of at least part of both the ovary and uterus can be proposed in patients with borderline ovarian tumour, in order to preserve fertility potential. This conservative management could be carried out even in patients with borderline ovarian tumour associated with non-invasive peritoneal implants (if complete resection of peritoneal disease has been performed). When facing persistent infertility after this conservative surgery, ovarian induction or an in-vitro procedure could be proposed in patients with an early-stage disease, though the number of attempts must be limited. Removal of the preserved ovary after completion of pregnancy(ies) is unnecessary if patients agree to careful follow-up. In patients with epithelial ovarian cancer, conservative management could safely be performed in young patients who wish to preserve fertility function and who fulfil the following criteria: unilateral tumour (stage IA), grade 1 (and 2?), adequate staging surgery and careful follow-up. Removal of the preserved ovary should be carried out after completion of pregnancy(ies) in order to reduce the risk of ovarian tumour recurrence.
引用
收藏
页码:185 / 192
页数:8
相关论文
共 83 条
[1]  
Baiocchi G, 1998, INT J GYNECOL CANCER, V8, P103
[2]   PRELIMINARY-ANALYSIS OF THE BEHAVIOR OF STAGE-I OVARIAN SEROUS TUMORS OF LOW MALIGNANT POTENTIAL - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY [J].
BARNHILL, DR ;
KURMAN, RJ ;
BRADY, MF ;
OMURA, GA ;
YORDAN, E ;
GIVEN, FT ;
KUCERA, PR ;
ROMAN, LD .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (11) :2752-2756
[3]  
Beiner ME, 2001, CANCER-AM CANCER SOC, V92, P320, DOI 10.1002/1097-0142(20010715)92:2<320::AID-CNCR1325>3.0.CO
[4]  
2-G
[5]  
BELL DA, 1988, CANCER, V62, P2212, DOI 10.1002/1097-0142(19881115)62:10<2212::AID-CNCR2820621024>3.0.CO
[6]  
2-W
[7]   ANATOMICAL AND PATHOLOGICAL-STUDY OF RETROPERITONEAL NODES IN EPITHELIAL OVARIAN-CANCER [J].
BENEDETTIPANICI, P ;
GREGGI, S ;
MANESCHI, F ;
SCAMBIA, G ;
AMOROSO, M ;
RABITTI, C ;
MANCUSO, S .
GYNECOLOGIC ONCOLOGY, 1993, 51 (02) :150-154
[8]   Occult bilateral involvement in Stage I epithelial ovarian cancer [J].
Benjamin, I ;
Morgan, MA ;
Rubin, SC .
GYNECOLOGIC ONCOLOGY, 1999, 72 (03) :288-291
[9]  
BOSTWICK DG, 1986, CANCER, V58, P2052, DOI 10.1002/1097-0142(19861101)58:9<2052::AID-CNCR2820580916>3.0.CO
[10]  
2-5